about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Mod­er­na, fac­ing rev­enue miss­es and po­lit­i­cal head­winds, dis­ap­points Wall Street

5 weeks ago
R&D
Pharma

Mod­er­na ex­pands ef­fort to rein in costs in an ‘un­cer­tain en­vi­ron­ment’

5 weeks ago
R&D
Pharma

Pfiz­er CEO Bourla sug­gests phar­ma tar­iffs will fo­cus on US ad­ver­saries, not al­lies

Last month
China
Pharma

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

Last month
Pharma

No­vavax re­sponds to FDA’s tri­al ask, with Covid vac­cine strain up­dates un­der scruti­ny

Last month
Pharma
FDA+

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

Last month
R&D
Pharma

Halozyme sues Mer­ck, al­leg­ing in­jectable Keytru­da will in­fringe its patents

Last month
Pharma
Law

Large vac­cine mak­ers stand by their in­vest­ments de­spite US head­winds

Last month
Pharma
FDA+

FDA asks No­vavax for post-mar­ket­ing da­ta of its Covid vac­cine, de­lay­ing ap­proval

Last month
Pharma
FDA+

CMS would ab­sorb 340B drug dis­count pro­gram un­der leaked HHS re­or­ga­ni­za­tion pro­pos­al

Last month
Pharma
FDA+

CDC ad­vi­sors broad­en RSV vac­cine rec­om­men­da­tions to at-risk adults in their 50s

Last month
R&D

At ACIP hear­ing, CDC says it's 'scrap­ing' to re­spond to measles out­break; FDA com­ments on No­vavax halt

Last month
Pharma
FDA+

Trump phar­ma tar­iffs inch clos­er as ad­min­is­tra­tion con­firms US trade probe

Last month
R&D
Pharma

CDC vac­cine ad­vi­sors are set to meet this week af­ter two-month de­lay and scruti­ny from Kennedy

Last month
R&D
Pharma

Vac­cines, obe­si­ty drugs, job cuts: Take­aways from RFK Jr.'s first net­work in­ter­view as HHS chief

Last month
People
Pharma

Phar­ma CEOs warn EU of po­ten­tial ‘ex­o­dus to the US’ as trade war con­tin­ues

Last month
Pharma
Manufacturing

Min­neso­ta fed­er­al judge dis­miss­es chal­lenge from Ab­b­Vie, As­traZeneca to state's 340B law

Last month
Pharma
Law

‘This is self-in­flict­ed’: Leerink’s David Risinger on the mar­ket shock and hits to bio­phar­ma

Last month
People
FDA+

RFK Jr. won’t tes­ti­fy be­fore key Sen­ate com­mit­tee this week on HHS over­haul

Last month
Pharma
FDA+

No­vavax’s held-up ap­proval pack­age may sig­nal warn­ing for Covid vac­cine mak­ers

Last month
R&D
Pharma

FDA will con­sol­i­date to five 'shared ser­vices of­fices,' ac­cord­ing to memo to Hill staffers

Last month
Pharma
FDA+

Chaot­ic tar­iff roll­out leaves as many ques­tions as an­swers for drug­mak­ers

Last month
Pharma
Manufacturing

FDA cuts stir buy­er’s re­morse for some bio­phar­ma lead­ers, once ex­cit­ed by Trump

Last month
Pharma
Cell/Gene Tx

Q&A: John Crow­ley warns biotech is 'dan­ger­ous­ly close' to break­ing, as tar­iff threat, mar­kets bat­ter in­dus­try

Last month
People
Pharma
First page Previous page 12345 Next page Last page
A service from the Financial Times